欧州の感染管理市場 – 2030年までの予測

European Infection Control Market - Forecast To 2030

欧州の感染管理市場 - 製品(滅菌装置(過酸化水素、エチレン)インジケーター)、サービス(ETO、ガンマ)、消毒剤(ワイプ、スプレー)、ガウン、ドレープ、内視鏡再処理、エンドユーザー(病院、製薬) - 2030年までの予測
European Infection Control Market by Product (Sterilization Equipment (Hydrogen Peroxide, Ethylene) Indicators), Service (ETO, Gamma), Disinfectants (Wipes, Sprays), Gown, Drapes, Endoscope Reprocessing, End User (Hospitals, Pharma) - Forecast to 2030

商品番号 : SMB-85991

出版社MarketsandMarkets
出版年月2025年9月
ページ数477
図表数515
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

本レポートは、製品・サービス、エンドユーザー、そして国別に、欧州の感染管理市場を分析しています。また、市場成長に影響を与える要因(推進要因、制約要因、機会、課題など)を分析するとともに、市場リーダーの競争環境の詳細も提供しています。さらに、ミクロ市場の成長傾向を分析し、13カ国における市場セグメントの収益予測も提供しています。

本レポートは、既存企業だけでなく新規参入企業や小規模企業も市場の動向を把握し、市場シェアの拡大に役立てることができます。本レポートを購入した企業は、以下に示す戦略のいずれか、または組み合わせて活用することで、市場でのプレゼンスを強化することができます。

欧州の感染制御市場は、予測期間中に6.6%のCAGRで成長し、2025年の149億9,000万米ドルから2030年には205億8,000万米ドルに達すると予測されています。

欧州の感染管理市場は、予測期間中に6.6%の年平均成長率(CAGR)で成長すると予測されています。市場の成長を牽引しているのは、手術件数の増加、再処理技術の進歩、食品の滅菌・消毒への関心の高まり、滅菌装置技術の進歩、そして製薬会社、医療機器メーカー、病院におけるアウトソーシングサービスの拡大です。

The European infection control market is projected to reach USD 20.58 billion by 2030 from USD 14.99 billion in 2025, at a CAGR of 6.6% during the forecast period.

The European infection control market is projected to grow at a  CAGR of 6.6% during the forecast period. The growth of the market is fuelled by the growing number of surgeries, advancements in reprocessing technologies, the increasing emphasis on sterilization & disinfection of food, advancements in sterilization equipment technology, and the rising trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals.

欧州の感染管理市場 - 2030年までの予測
european-infection-control-market-Overview

By product & service, the cleaning & disinfection products segment accounted for the largest share of the market in 2024.

By product & service, the European infection control market is segmented into sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products. In 2024, the cleaning & disinfection products segment accounted for the largest share of the European infection control market. The large share of this segment is attributed to the rising incidence of chronic diseases, stringent regulatory standards, advancements in sterilization technologies, and the favourable government support for healthcare procedures.

By end user, the hospitals & clinics segment accounted for the largest share of the market in 2024.

Based on end users, the European infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other end users. The hospitals & clinics segment accounted for the largest share of the European infection control market in 2024. The increasing number of surgical procedures and government initiatives to improve infection prevention and control have prompted greater awareness and implementation of rigorous standards.

欧州の感染管理市場 - 2030年までの予測 region
european-infection-control-market-Region

By country, Germany is expected to dominate the European infection control market during the forecast period.

The European infection control market is segmented into 13 countries: Germany, the UK, France, Italy, Spain, Switzerland, Poland, Austria, Romania, the Czech Republic, Slovakia, Portugal, and the rest of Europe. Germany is projected to dominate the market during the forecast period, owing to several reinforcing factors such as strong regulatory backing through national public health initiatives and infection control programs; high healthcare expenditure; and adoption of technologically advanced infection control products, including automated disinfection systems and professional training protocols.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35%
  • By Designation: C Level: 27%, Director Level: 18%, and Others: 55%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the European infection control market are STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), Solventum Corporation (US), Advanced Sterilization Products (US), Kimberly Clark Corporation (US), B. Braun Group (Germany), Olympus Corporation (Japan), Paul Hartmann AG (Germany), Reckitt Benckiser (UK), Cardinal Health (US), Miele Group (Germany), MMM Group (Germany), MATACHANA GROUP (Spain), and Medline Industries, LP (US), among others.

欧州の感染管理市場 - 2030年までの予測 ecosystem
european-infection-control-market-Ecosystem

Research Coverage

This report studies the European infection control market based on product & service, end user, and countries. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Additionally, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments in 13 countries.

Reasons to Buy the Report

The report will enable established and entrant/smaller firms to gauge the market’s pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights into the following points:

Analysis of key drivers (Rising prevalence of HAIs in Europe, growing number of surgeries, advancement in reprocessing technologies, rising emphasis on sterilization and disinfection of food, advancements in sterilization equipment technology, and the growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals), restraints (growing concerns about safety of reprocessed instruments, consequences associated with use of chemical disinfectants, and the high cost associated with endoscopy reprocessing coupled with limited reimbursements in emerging economies), opportunities (implementation of stringent eu guidelines and mdr compliance and growing utilization of e-beam sterilization), challenges (sterilization of advanced medical devices, alternative methods for surface disinfection, and increasing adoption of single-use medical nonwovens and devices).

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the European infection control market
  • Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the European infection control market
  • Market Development: Comprehensive information on lucrative countries
  • Market Diversification: Exhaustive information about new products and recent developments in the European infection control market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

Table of Contents

1               INTRODUCTION              35

1.1           STUDY OBJECTIVES       35

1.2           MARKET DEFINITION   35

1.2.1        INCLUSIONS & EXCLUSIONS       36

1.3           MARKET SCOPE                37

1.3.1        MARKETS COVERED       37

1.3.2        REGIONS COVERED        38

1.3.3        YEARS CONSIDERED      38

1.3.4        CURRENCY CONSIDERED            38

1.4           STAKEHOLDERS               38

2               RESEARCH METHODOLOGY       40

2.1           RESEARCH DATA              40

2.1.1        SECONDARY DATA          41

2.1.1.1    Key data from secondary sources       41

2.1.2        PRIMARY DATA 42

2.1.2.1    Primary sources    42

2.1.2.2    Key industry insights           43

2.1.2.3    Key data from primary sources           43

2.1.2.4    Breakdown of primary interviews      44

2.2           MARKET SIZE ESTIMATION         44

2.2.1        BOTTOM-UP APPROACH              45

2.2.1.1    Approach 1: Company revenue estimation approach     45

2.2.1.2    Approach 2: Presentations of companies & primary interviews                 46

2.2.1.3    Approach 3: Primary interviews         46

2.2.1.4    Approach 4: Growth forecast              46

2.2.1.5    CAGR projections                 46

2.2.2        TOP-DOWN APPROACH                47

2.3           MARKET BREAKDOWN & DATA TRIANGULATION                 47

2.4           RESEARCH ASSUMPTIONS           49

2.4.1        STUDY-RELATED ASSUMPTIONS              49

2.4.2        GROWTH RATE ASSUMPTIONS 49

2.5           RISK ASSESSMENT           50

2.6           RESEARCH LIMITATIONS             50

3               EXECUTIVE SUMMARY  51

4               PREMIUM INSIGHTS       55

4.1           EUROPEAN INFECTION CONTROL MARKET OVERVIEW                 55

4.2           EUROPEAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE AND COUNTRY (2024)       56

4.3           EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY, 2025 VS. 2030                57

4.4           EUROPEAN INFECTION CONTROL MARKET: COUNTRY MIX, 2025 VS. 2030             58

5               MARKET OVERVIEW       59

5.1           INTRODUCTION              59

5.2           MARKET DYNAMICS       59

5.2.1        DRIVERS               60

5.2.1.1    Rising prevalence of HAIs  60

5.2.1.2    Increasing number of surgical procedures        61

5.2.1.3    Advancements in reprocessing technologies    62

5.2.1.4    Increasing emphasis on sterilization & disinfection of food                 63

5.2.1.5    Advancements in sterilization equipment technology    63

5.2.2        RESTRAINTS      64

5.2.2.1    Growing concerns about safety of reprocessed instruments                 64

5.2.2.2    Consequences associated with chemical disinfectant use                 65

5.2.2.3    High cost of endoscopy reprocessing and limited reimbursements                 66

5.2.3        OPPORTUNITIES              66

5.2.3.1    Implementation of stringent EU guidelines and MDR compliance                 66

5.2.3.2    Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals              67

5.2.3.3    Growing utilization of E-beam sterilization     67

5.2.4        CHALLENGES    68

5.2.4.1    Sterilization of advanced medical devices         68

5.2.4.2    Alternative methods for surface disinfection   68

5.2.4.3    Increasing adoption of single-use medical devices          69

5.3           PRICING ANALYSIS          69

5.3.1        AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER,

2022–2024              70

5.3.2        AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022–2024           71

5.3.3        AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2022−2024            71

5.4           VALUE CHAIN ANALYSIS               73

5.4.1        RESEARCH & DEVELOPMENT    73

5.4.2        RAW MATERIAL SUPPLIERS         73

5.4.3        MANUFACTURING          73

5.4.4        DISTRIBUTION 73

5.4.5        MARKETING, AND SALES              73

5.4.6        POST-SALES SERVICES  74

5.5           SUPPLY CHAIN ANALYSIS             74

5.5.1        PROMINENT COMPANIES            74

5.5.2        SMALL & MEDIUM–SIZED ENTERPRISES                75

5.5.3        END USERS         75

5.6           ECOSYSTEM ANALYSIS  75

5.7           TECHNOLOGY ANALYSIS             77

5.7.1        KEY TECHNOLOGIES     77

5.7.1.1    Heat sterilization  77

5.7.1.2    Low-temperature sterilization            77

5.7.2        COMPLEMENTARY TECHNOLOGIES       78

5.7.2.1    Supercritical Co2 technology              78

5.7.2.2    Ultra-high-pressure sterilization        78

5.7.2.3    PEF sterilization   78

5.7.2.4    Plasma sterilization              78

5.8           PORTER’S FIVE FORCES ANALYSIS           79

5.8.1        THREAT OF NEW ENTRANTS      80

5.8.2        THREAT OF SUBSTITUTES          81

5.8.3        BARGAINING POWER OF SUPPLIERS       81

5.8.4        BARGAINING POWER OF BUYERS             81

5.8.5        INTENSITY OF COMPETITIVE RIVALRY 81

5.9           REGULATORY ANALYSIS               81

5.9.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             82

5.9.2        REGULATORY LANDSCAPE         82

5.9.2.1    Europe   82

5.9.2.1.1 Germany                 84

5.9.2.1.2 UK          84

5.9.2.1.3 France    84

5.9.2.1.4 Italy         85

5.9.2.1.5 Spain      85

5.10         PATENT ANALYSIS          86

5.11         TRADE ANALYSIS             87

5.11.1      IMPORT DATA FOR HS CODE 841920       88

5.11.2      EXPORT DATA FOR HS CODE 841920       88

5.12         KEY CONFERENCES & EVENTS, 2025–2026              89

5.13         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       89

5.14         KEY STAKEHOLDERS & BUYING CRITERIA            90

5.14.1      KEY STAKEHOLDERS IN BUYING PROCESS           90

5.14.2      BUYING CRITERIA           91

5.15         INVESTMENT & FUNDING SCENARIO     92

5.16         IMPACT OF AI/GENERATIVE AI ON EUROPEAN INFECTION CONTROL MARKET                94

5.16.1      INTRODUCTION              94

5.16.2      POTENTIAL OF AI IN EUROPEAN INFECTION CONTROL MARKET               94

5.16.3      AI USE CASES     95

5.16.4      KEY COMPANIES IMPLEMENTING AI      96

5.16.5      FUTURE OF GENERATIVE AI IN EUROPEAN INFECTION CONTROL MARKET         96

5.17         TRUMP TARIFF IMPACT ON EUROPEAN INFECTION CONTROL MARKET         96

5.17.1      INTRODUCTION              96

5.17.2      KEY TARIFF RATES          97

5.17.3      IMPACT OF TARIFFS ON PRICING             98

5.17.4      KEY IMPACT ON EUROPE             99

5.17.5      END-USER INDUSTRY IMPACT  99

6               INFECTION CONTROL MARKET, BY PRODUCT & SERVICE               101

6.1           INTRODUCTION              102

6.2           STERILIZATION PRODUCTS & SERVICES               102

6.2.1        STERILIZATION EQUIPMENT     105

6.2.1.1    Heat sterilization equipment               108

6.2.1.1.1 Moist heat sterilizers            111

6.2.1.1.1.1              Versatility across material testing to fuel market                 111

6.2.1.1.2 Dry heat sterilizers               113

6.2.1.1.2.1              Increasing demand for heat-sensitive instruments to boost demand        113

6.2.1.2    Low-temperature sterilization            114

6.2.1.2.1 Hydrogen peroxide sterilization         116

6.2.1.2.1.1              Effective application across broad industries to fuel market    116

6.2.1.2.2 Ethylene oxide (EtO) sterilization     118

6.2.1.2.2.1              High penetration capabilities to fuel uptake    118

6.2.1.2.3 Formaldehyde sterilization 120

6.2.1.2.3.1              Potent antimicrobial properties to aid adoption                 120

6.2.1.2.4 Other low-temperature sterilization products 121

6.2.1.3    Radiation sterilization          122

6.2.1.3.1 Utilization across pharmaceutical & biopharmaceutical sectors for vaccines & biologics to drive market            122

6.2.2        CONTRACT STERILIZATION SERVICES MARKET                 124

6.2.2.1    EtO sterilization services    126

6.2.2.1.1 Expanding applications across medical device sterilization and life sciences industry to fuel market  126

6.2.2.2    Gamma sterilization services              128

6.2.2.2.1 Minimal chemical residue and ability to penetrate dense materials to fuel uptake        128

6.2.2.3    E-beam sterilization services               130

6.2.2.3.1 Rapid processing and precise control to boost market   130

6.2.2.4    Steam sterilization services 131

6.2.2.4.1 Standard method with optimal efficiency to drive market                 131

6.2.2.5    Other contract sterilization services  133

6.2.3        CONSUMABLES & ACCESSORIES                135

6.2.3.1    Sterilization indicators         137

6.2.3.1.1 Chemical indicators              139

6.2.3.1.1.1              Cost-efficiency and simplicity to fuel uptake   139

6.2.3.1.2 Biological indicators             140

6.2.3.1.2.1              Consistent and precise testing features for clinical settings to boost demand    140

6.2.3.2    Sterilization pouches            142

6.2.3.2.1 Sterility maintenance with time duration to aid adoption                 142

6.2.3.3    Sterilization lubricants         143

6.2.3.3.1 Prevention of equipment damage to support market growth                 143

6.2.3.4    Sterilization accessories       145

6.2.3.4.1 Utilization across healthcare & pharma industries to fuel demand                 145

6.3           CLEANING & DISINFECTION PRODUCTS               148

6.3.1        DISINFECTANTS               152

6.3.1.1    Disinfectants, by product type            153

6.3.1.1.1 Hand disinfectants                154

6.3.1.1.1.1              Rising awareness about health & hygiene to boost market    154

6.3.1.1.2 Surface disinfectants            156

6.3.1.1.2.1              Increasing prevalence of HAIs to fuel market  156

6.3.1.1.3 Skin disinfectants 158

6.3.1.1.3.1              Increasing incidence of infectious diseases to fuel market    158

6.3.1.1.4 Instrument disinfectants     160

6.3.1.1.4.1              Growing number of surgical procedures to boost demand  160

6.3.1.2    Disinfectants, by formulation             163

6.3.1.2.1 Liquid disinfectants              163

6.3.1.2.1.1              Effective utilization and high affordability to propel market    163

6.3.1.2.2 Disinfectant wipes                165

6.3.1.2.2.1              Easy accessibility to support market growth    165

6.3.1.2.3 Disinfectant sprays               167

6.3.1.2.3.1              Increasing usage of antimicrobial control measures to fuel demand           167

6.3.1.3    Disinfectants, by EPA classification  169

6.3.1.3.1 Low-level disinfectants        169

6.3.1.3.1.1              Effective elimination of vegetative bacteria and most viruses to boost demand      169

6.3.1.3.2 Intermediate-level disinfectants         170

6.3.1.3.2.1              Applications across dentistry and environmental monitoring to boost demand               170

6.3.1.3.3 High-level disinfectants       171

6.3.1.3.3.1              Sterilization of medical devices and semi-critical instruments across clinical settings to propel uptake      171

6.3.2        CLEANING & DISINFECTION EQUIPMENT            172

6.3.2.1    Washer disinfectors              174

6.3.2.1.1 Utilization of high-pressure water jets and detergents for disinfection to fuel market  174

6.3.2.2    Flusher disinfectors              176

6.3.2.2.1 Innovative product launches to boost demand 176

6.3.2.3    UV-ray disinfectors              178

6.3.2.3.1 Elimination of plethora of viruses, bacteria, and fungi to propel market    178

6.3.2.4    Ultrasonic cleaners               180

6.3.2.4.1 Utilization of high-frequency sound waves for microscopic dirt clearance to aid adoption    180

6.3.2.5    Other cleaning & disinfection equipment         181

6.3.3        LUBRICANTS & CLEANING SOLUTIONS 182

6.3.3.1    Utilization for disinfection of reprocessing instruments to drive market    182

6.3.4        DISINFECTION & CLEANING ACCESSORIES         184

6.3.4.1    Stringent regulatory standards to support market growth                 184

6.4           PROTECTIVE BARRIERS                 185

6.4.1        MEDICAL NONWOVENS                187

6.4.1.1    Face masks             189

6.4.1.1.1 Increasing prevalence of respiratory diseases to drive market                 189

6.4.1.2    Surgical gowns      190

6.4.1.2.1 Growing awareness about infection control to fuel market                 190

6.4.1.3    Surgical drapes     192

6.4.1.3.1 Prevention of microorganism transfer from non-sterile surfaces to fuel uptake        192

6.4.2        GLOVES                193

6.4.2.1    Growing concerns related to personnel safety to fuel uptake                 193

6.4.3        COVERS & CLOSURES     194

6.4.3.1    Growing focus on food safety to fuel demand 194

6.4.4        GOGGLES            195

6.4.4.1    Increasing use of protective gear in research laboratories to support market growth        195

6.5           ENDOSCOPE REPROCESSING PRODUCTS             196

6.5.1        ENDOSCOPE REPROCESSING CONSUMABLES    199

6.5.1.1    RECURRING NATURE TO FUEL UPTAKE                199

6.5.2        ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS        201

6.5.2.1    Automated endoscope reprocessors  202

6.5.2.1.1 Enhanced efficiency of AERs compared to manual cleaning to fuel uptake             202

6.5.2.2    Endoscope tracking solutions             204

6.5.2.2.1 Ability to provide efficient traceability to fuel uptake    204

6.5.3        OTHER ENDOSCOPE REPROCESSING EQUIPMENT                 205

6.6           OTHER INFECTION CONTROL PRODUCTS          207

7               INFECTION CONTROL MARKET, BY END USER  209

7.1           INTRODUCTION              210

7.2           HOSPITALS & CLINICS   210

7.2.1        STRINGENT CLEANLINESS PROTOCOLS FOR RESTRICTION OF HAIS TO PROPEL MARKET      210

7.3           MEDICAL DEVICE COMPANIES 213

7.3.1        RISING TECHNOLOGICAL INNOVATIONS IN INFECTION CONTROL PRODUCTS TO DRIVE MARKET           213

7.4           PHARMACEUTICAL COMPANIES               215

7.4.1        GROWING NEED FOR SAFETY ASSURANCE AND REGULATORY APPROVALS TO BOOST MARKET                215

7.5           LIFE SCIENCES INDUSTRY            216

7.5.1        INCREASING FOCUS ON CLINICAL RESEARCH INITIATIVES TO FUEL MARKET 216

7.6           FOOD INDUSTRY             218

7.6.1        RISING INCIDENCE OF FOODBORNE DISEASES TO SUPPORT MARKET GROWTH     218

7.7           OTHER END USERS         219

8               EUROPEAN INFECTION CONTROL MARKET, BY REGION                 221

8.1           INTRODUCTION              222

8.2           EUROPE               223

8.2.1        MACROECONOMIC OUTLOOK FOR EUROPE      225

8.2.2        GERMANY           235

8.2.2.1    Growing adoption of hospital disinfection & surveillance systems to drive market      235

8.2.3        UK          244

8.2.3.1    High prevalence of HAIS to drive market         244

8.2.4        FRANCE                254

8.2.4.1    Stringent regulatory guidelines for infection control product commercialization to fuel uptake       254

8.2.5        ITALY    264

8.2.5.1    Increasing establishment of long-term care facilities to boost demand  264

8.2.6        SPAIN    273

8.2.6.1    Increasing prevalence of infectious diseases to fuel market                 273

8.2.7        SWITZERLAND 283

8.2.7.1    Heightened burden of CAUTI to drive market                283

8.2.8        POLAND               292

8.2.8.1    Growing volume of surgeries to fuel uptake     292

8.2.9        AUSTRIA              301

8.2.9.1    Rising incidence of notifiable infectious diseases to drive market                 301

8.2.10      ROMANIA            311

8.2.10.1  Efficient implementation of disease surveillance systems to boost demand  311

8.2.11      CZECH REPUBLIC            321

8.2.11.1  Growing number of surgical & dental procedures to fuel market                 321

8.2.12      SLOVAKIA           330

8.2.12.1  Improvements in healthcare infrastructure to boost demand                 330

8.2.13      PORTUGAL         339

8.2.13.1  Rising prevalence of chronic conditions to drive market                 339

8.2.14      REST OF EUROPE             348

9               COMPETITIVE LANDSCAPE         359

9.1           INTRODUCTION              359

9.2           KEY PLAYER STRATEGIES/RIGHT TO WIN            359

9.2.1        OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET  359

9.3           REVENUE ANALYSIS, 2020−2024                 360

9.4           MARKET SHARE ANALYSIS, 2024                 361

9.5           COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 364

9.5.1        STARS   364

9.5.2        EMERGING LEADERS     364

9.5.3        PERVASIVE PLAYERS      364

9.5.4        PARTICIPANTS 364

9.5.5        COMPANY FOOTPRINT: KEY PLAYERS, 2024         366

9.5.5.1    Company footprint               366

9.5.5.2    Region footprint   367

9.5.5.3    Product & service footprint 368

9.5.5.4    End-user footprint                369

9.6           COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        370

9.6.1        PROGRESSIVE COMPANIES         370

9.6.2        RESPONSIVE COMPANIES            370

9.6.3        DYNAMIC COMPANIES  370

9.6.4        STARTING BLOCKS         370

9.6.5        COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 372

9.6.5.1    Detailed list of key startup/SME players          372

9.6.5.2    Competitive benchmarking of key startups/SMEs          373

9.7           COMPANY VALUATION AND FINANCIAL METRICS                 374

9.7.1        FINANCIAL METRICS      374

9.7.2        COMPANY VALUATION 374

9.8           BRAND/PRODUCT COMPARISON             375

9.9           COMPETITIVE SCENARIO             376

9.9.1        PRODUCT LAUNCHES   376

9.9.2        DEALS  377

9.9.3        EXPANSIONS     378

10            COMPANY PROFILES      379

10.1         KEY PLAYERS     379

10.1.1      STERIS  379

10.1.1.1  Business overview 379

10.1.1.2  Products/Services offered   380

10.1.1.3  Recent developments           384

10.1.1.3.1                Deals      384

10.1.1.4  MnM view              384

10.1.1.4.1                Key strengths        384

10.1.1.4.2                Strategic choices   385

10.1.1.4.3                Weaknesses & competitive threats     385

10.1.2      RECKITT BENCKISER     386

10.1.2.1  Business overview 386

10.1.2.2  Products/Services offered   387

10.1.2.3  Recent developments           388

10.1.2.3.1                Deals      388

10.1.2.4  MnM view              388

10.1.2.4.1                Key strengths        388

10.1.2.4.2                Strategic choices   389

10.1.2.4.3                Weaknesses & competitive threats     389

10.1.3      PAUL HARTMANN            390

10.1.3.1  Business overview 390

10.1.3.2  Products/Services offered   391

10.1.3.3  MnM view              392

10.1.3.3.1                Key strengths        392

10.1.3.3.2                Strategic choices   392

10.1.3.3.3                Weaknesses & competitive threats     392

10.1.4      ECOLAB, INC.    393

10.1.4.1  Business overview 393

10.1.4.2  Products/Services offered   394

10.1.4.3  Recent developments           401

10.1.4.3.1                Deals      401

10.1.4.3.2                Product/Service launches   401

10.1.4.4  MnM view              401

10.1.4.4.1                Key strengths        401

10.1.4.4.2                Strategic choices   402

10.1.4.4.3                Weaknesses & competitive threats     402

10.1.5      B. BRAUN SE       403

10.1.5.1  Business overview 403

10.1.5.2  Products/Services offered   404

10.1.5.3  Recent developments           405

10.1.5.3.1                Other developments             405

10.1.5.4  MnM view              405

10.1.5.4.1                Key strengths        405

10.1.5.4.2                Strategic choices   406

10.1.5.4.3                Weaknesses & competitive threats     406

10.1.6      GETINGE AB      407

10.1.6.1  Business overview 407

10.1.6.2  Products/Services offered   408

10.1.6.3  Recent developments           413

10.1.6.3.1                Deals      413

10.1.6.3.2                Product/Service launches   414

10.1.7      ADVANCED STERILIZATION PRODUCTS (SUBSIDIARY OF FORTIVE CORPORATION)     415

10.1.7.1  Business overview 415

10.1.7.2  Products/Services offered   416

10.1.8      SOLVENTUM CORPORATION     418

10.1.8.1  Business overview 418

10.1.8.2  Products/Services offered   419

10.1.9      KIMBERLY-CLARK CORPORATION           424

10.1.9.1  Business overview 424

10.1.9.2  Products/Services offered   425

10.1.10   OLYMPUS CORPORATION           427

10.1.10.1                 Business overview 427

10.1.10.2                 Products/Services offered   428

10.1.10.3                 Recent developments           429

10.1.10.3.1             Deals      429

10.1.10.3.2             Product/Service launches   430

10.1.10.3.3             Other developments             431

10.1.11   CARDINAL HEALTH        432

10.1.11.1                 Business overview 432

10.1.11.2                 Products/Services offered   433

10.1.11.3                 Recent developments           435

10.1.11.3.1             Other developments             435

10.1.12   THE MIELE GROUP (JOINT VENTURE WITH STEELCOBELIMED AG) 436

10.1.12.1                 Business overview 436

10.1.12.2                 Products/Services offered   436

10.1.12.3                 Recent developments           443

10.1.12.3.1             Deals      443

10.1.13   MMM GROUP    444

10.1.13.1                 Business overview 444

10.1.13.2                 Products/Services offered   444

10.1.13.3                 Recent developments           446

10.1.13.3.1             Product/Service launches   446

10.1.14   MATACHANA GROUP    447

10.1.14.1                 Business overview 447

10.1.14.2                 Products/Services offered   447

10.1.15   MEDLINE INDUSTRIES, LP           450

10.1.15.1                 Business overview 450

10.1.15.2                 Products/Services offered   450

10.2         OTHER PLAYERS              452

10.2.1      CONTEC, INC.   452

10.2.2      DE LAMA SPA    455

10.2.3      SYSTEC GMBH & CO. KG               456

10.2.4      PAL INTERNATIONAL    457

10.2.5      MELAG MEDIZINTECHNIK GMBH & CO. KG         459

10.2.6      MEDALKAN        460

10.2.7      C.B.M. S.R.L. MEDICAL EQUIPMENT        462

10.2.8      DR. SCHUMACHER GMBH            463

10.2.9      ACTO GMBH      464

10.2.10   ULTRAWAVE      465

11            APPENDIX           466

11.1         DISCUSSION GUIDE        466

11.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                473

11.3         CUSTOMIZATION OPTIONS        475

11.4         RELATED REPORTS         475

11.5         AUTHOR DETAILS           476

LIST OF TABLES

TABLE 1                EUROPEAN INFECTION CONTROL MARKET: INCLUSIONS & EXCLUSIONS       36

TABLE 2                EUROPEAN INFECTION CONTROL MARKET: RISK ASSESSMENT ANALYSIS      50

TABLE 3                EUROPE: PREVALENCE OF HAIS IN ACUTE CARE HOSPITALS, BY HAI TYPE,

2022–2023              60

TABLE 4                GERMANY: SURGERY TYPES FOR INPATIENT HOSPITAL VISITS, 2023  62

TABLE 5                AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS,

BY KEY PLAYER, 2022–2024 (USD)              70

TABLE 6                AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS,

BY REGION, 2022–2024 (USD)      71

TABLE 7                AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS,

BY TYPE, 2022–2024 (USD)            72

TABLE 8                EUROPEAN INFECTION CONTROL MARKET: ROLE IN ECOSYSTEM     76

TABLE 9                EUROPEAN INFECTION CONTROL MARKET: PORTER’S FIVE FORCES ANALYSIS           79

TABLE 10              EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  82

TABLE 11              STANDARDS RELATED TO DESIGNATING MEDICAL DEVICES AS STERILE 83

TABLE 12              STERILIZATION STANDARDS IN EUROPEAN UNION 83

TABLE 13              LIST OF PATENTS IN EUROPEAN INFECTION CONTROL MARKET, 2022–2024   87

TABLE 14              IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2019–2024 (USD MILLION)     88

TABLE 15              EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2019–2024 (USD MILLION)     88

TABLE 16              EUROPEAN INFECTION CONTROL MARKET: KEY CONFERENCES & EVENTS, 2025−2026            89

TABLE 17              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP

THREE PRODUCTS (%) 91

TABLE 18              KEY BUYING CRITERIA FOR TOP THREE PRODUCTS         92

TABLE 19              ADOPTION OF AI BY KEY INDUSTRY PLAYERS                 96

TABLE 20              US-ADJUSTED RECIPROCAL TARIFF RATES                 97

TABLE 21              INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            102

TABLE 22              KEY PLAYERS PROVIDING STERILIZATION PRODUCTS         103

TABLE 23              STERILIZATION PRODUCTS & SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            104

TABLE 24              EUROPE: STERILIZATION PRODUCTS & SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            105

TABLE 25              KEY PLAYERS PROVIDING STERILIZATION EQUIPMENT      106

TABLE 26             STERILIZATION EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)            107

TABLE 27             EUROPE: STERILIZATION EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            108

TABLE 28              KEY PLAYERS PROVIDING HEAT STERILIZATION EQUIPMENT     109

TABLE 29              HEAT STERILIZATION EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)                110

TABLE 30              EUROPE: HEAT STERILIZATION EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 31              MOIST HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS           111

TABLE 32              EUROPE: MOIST HEAT STERILIZERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            112

TABLE 33              DRY HEAT STERILIZERS OFFERED BY KEY MARKET PLAYERS           113

TABLE 34              EUROPE: DRY HEAT STERILIZERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 35              LOW-TEMPERATURE STERILIZERS OFFERED BY KEY MARKET PLAYERS  115

TABLE 36              LOW-TEMPERATURE STERILIZATION MARKET, BY TYPE,

2023–2030 (USD MILLION)            115

TABLE 37              EUROPE: LOW-TEMPERATURE STERILIZATION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            116

TABLE 38              HYDROGEN PEROXIDE STERILIZERS OFFERED BY KEY MARKET PLAYERS            117

TABLE 39              GLOBAL INSTALLED UNITS OF LOW-TEMPERATURE HYDROGEN PEROXIDE GAS PLASMA STERILIZERS, 2023–2030 (UNITS)                117

TABLE 40              EUROPE: HYDROGEN PEROXIDE STERILIZERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            118

TABLE 41              ETO STERILIZERS OFFERED BY KEY MARKET PLAYERS              119

TABLE 42              EUROPE: ETO STERILIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     119

TABLE 43              FORMALDEHYDE STERILIZERS OFFERED BY KEY MARKET PLAYERS  120

TABLE 44              EUROPE: FORMALDEHYDE STERILIZERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            121

TABLE 45              EUROPE: OTHER LOW-TEMPERATURE STERILIZATION PRODUCTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               122

TABLE 46              RADIATION STERILIZERS OFFERED BY KEY MARKET PLAYERS           123

TABLE 47              EUROPE: RADIATION STERILIZATION MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            124

TABLE 48              CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS       125

TABLE 49              CONTRACT STERILIZATION SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            125

TABLE 50              EUROPE: CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            126

TABLE 51              ETO STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS  127

TABLE 52              EUROPE: ETO STERILIZATION SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            128

TABLE 53              GAMMA STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS  129

TABLE 54              EUROPE: GAMMA STERILIZATION SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            129

TABLE 55              E-BEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS  130

TABLE 56              EUROPE: E-BEAM STERILIZATION SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            131

TABLE 57              STEAM STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS  132

TABLE 58              EUROPE: STEAM STERILIZATION SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            133

TABLE 59              OTHER CONTRACT STERILIZATION SERVICES OFFERED BY KEY MARKET PLAYERS       134

TABLE 60              EUROPE: OTHER CONTRACT STERILIZATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 135

TABLE 61              CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)                136

TABLE 62              EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            136

TABLE 63              STERILIZATION INDICATORS OFFERED BY KEY MARKET PLAYERS           137

TABLE 64             STERILIZATION INDICATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)            138

TABLE 65             EUROPE: STERILIZATION INDICATORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            138

TABLE 66              CHEMICAL INDICATORS OFFERED BY KEY MARKET PLAYERS           139

TABLE 67              EUROPE: CHEMICAL INDICATORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            140

TABLE 68              BIOLOGICAL INDICATORS OFFERED BY KEY MARKET PLAYERS           141

TABLE 69              EUROPE: BIOLOGICAL INDICATORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          141

TABLE 70              STERILIZATION POUCHES OFFERED BY KEY MARKET PLAYERS           142

TABLE 71              EUROPE: STERILIZATION POUCHES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            143

TABLE 72              STERILIZATION LUBRICANTS OFFERED BY KEY MARKET PLAYERS           144

TABLE 73              EUROPE: STERILIZATION LUBRICANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            144

TABLE 74              STERILIZATION ACCESSORIES OFFERED BY KEY MARKET PLAYERS           145

TABLE 75              EUROPE: STERILIZATION ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            147

TABLE 76              CLEANING & DISINFECTION PRODUCTS OFFERED BY KEY MARKET PLAYERS       148

TABLE 77              CLEANING & DISINFECTION PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            151

TABLE 78              EUROPE: CLEANING & DISINFECTION PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            151

TABLE 79              COMMON DISINFECTANTS USED IN INDUSTRIAL SETTINGS 152

TABLE 80              EUROPE: DISINFECTANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     153

TABLE 81              DISINFECTANTS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            154

TABLE 82              HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS           155

TABLE 83              EUROPE: HAND DISINFECTANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 84              SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS           156

TABLE 85              EUROPE: SURFACE DISINFECTANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            157

TABLE 86              SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS           158

TABLE 87              EUROPE: SKIN DISINFECTANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            160

TABLE 88              INSTRUMENT DISINFECTANTS OFFERED BY KEY MARKET PLAYERS  161

TABLE 89              EUROPE: INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            162

TABLE 90              DISINFECTANTS MARKET, BY FORMULATION, 2023–2030 (USD MILLION)            163

TABLE 91              LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS           164

TABLE 92              EUROPE: LIQUID DISINFECTANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          165

TABLE 93              DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS           166

TABLE 94              EUROPE: DISINFECTANT WIPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            167

TABLE 95              DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS           168

TABLE 96              EUROPE: DISINFECTANT SPRAYS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 97              DISINFECTANTS MARKET, BY EPA CLASSIFICATION, 2023–2030 (USD MILLION)       169

TABLE 98             EUROPE: LOW-LEVEL DISINFECTANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            170

TABLE 99              EUROPE: INTERMEDIATE-LEVEL DISINFECTANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            171

TABLE 100            EUROPE: HIGH-LEVEL DISINFECTANTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            172

TABLE 101            CLEANING & DISINFECTION EQUIPMENT OFFERED BY KEY MARKET PLAYERS       173

TABLE 102            CLEANING & DISINFECTION EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            173

TABLE 103            EUROPE: CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            174

TABLE 104            WASHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS           175

TABLE 105            EUROPE: WASHER DISINFECTORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            176

TABLE 106            FLUSHER DISINFECTORS OFFERED BY KEY MARKET PLAYERS           177

TABLE 107            EUROPE: FLUSHER DISINFECTORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            178

TABLE 108            UV-RAY DISINFECTORS OFFERED BY KEY MARKET PLAYERS           179

TABLE 109            EUROPE: UV-RAY DISINFECTORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            180

TABLE 110            EUROPE: ULTRASONIC CLEANERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            181

TABLE 111            EUROPE: OTHER CLEANING & DISINFECTION EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 182

TABLE 112            LUBRICANTS & CLEANING SOLUTIONS OFFERED BY KEY MARKET PLAYERS       183

TABLE 113            EUROPE: LUBRICANTS & CLEANING SOLUTIONS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            184

TABLE 114            EUROPE: DISINFECTION & CLEANING ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 185

TABLE 115            PROTECTIVE BARRIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            186

TABLE 116            EUROPE: PROTECTIVE BARRIERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            186

TABLE 117            MEDICAL NONWOVENS OFFERED BY KEY MARKET PLAYERS           187

TABLE 118            MEDICAL NONWOVENS MARKET, BY TYPE, 2023–2030 (USD MILLION)            188

TABLE 119            EUROPE: MEDICAL NONWOVENS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            188

TABLE 120            EUROPE: FACE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            189

TABLE 121            LEVELS OF SURGICAL GOWNS  190

TABLE 122            EUROPE: SURGICAL GOWNS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     191

TABLE 123            EUROPE: SURGICAL DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     193

TABLE 124            EUROPE: GLOVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       194

TABLE 125            EUROPE: COVERS & CLOSURES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            195

TABLE 126            EUROPE: GOGGLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            196

TABLE 127            ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY KEY MARKET PLAYERS       197

TABLE 128            ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            198

TABLE 129            EUROPE: ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            198

TABLE 130            ENDOSCOPE REPROCESSING CONSUMABLES OFFERED BY KEY MARKET PLAYERS       199

TABLE 131            EUROPE: ENDOSCOPE REPROCESSING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            200

TABLE 132            ENDOSCOPE REPROCESSING EQUIPMENT MARKET, BY TYPE,

2023–2030 (USD MILLION)            201

TABLE 133            EUROPE: ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               202

TABLE 134            AUTOMATED ENDOSCOPE REPROCESSORS OFFERED BY KEY MARKET PLAYERS       203

TABLE 135            EUROPE: AUTOMATED ENDOSCOPE REPROCESSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            204

TABLE 136            ENDOSCOPE TRACKING SOLUTIONS OFFERED BY KEY MARKET PLAYERS            205

TABLE 137            EUROPE: ENDOSCOPE TRACKING SOLUTIONS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            205

TABLE 138            OTHER ENDOSCOPE REPROCESSING PRODUCTS OFFERED BY

KEY MARKET PLAYERS  206

TABLE 139            EUROPE: OTHER ENDOSCOPE REPROCESSING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 207

TABLE 140            EUROPE: OTHER INFECTION CONTROL PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            208

TABLE 141            INFECTION CONTROL MARKET, BY END USER, 2023–2030 (USD MILLION)            210

TABLE 142            EXAMPLES OF CRITICAL-ACCESS HOSPITALS IMPLEMENTING

EVIDENCE-BASED PROGRAMS FOR HAIS               211

TABLE 143            EUROPE: INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               213

TABLE 144            EUROPE: INFECTION CONTROL MARKET FOR MEDICAL DEVICE COMPANIES,

BY COUNTRY, 2023–2030 (USD MILLION)               214

TABLE 145            DIFFERENT METHODS OF STERILIZATION IN PHARMACEUTICAL COMPANIES               215

TABLE 146            EUROPE: INFECTION CONTROL MARKET FOR PHARMACEUTICAL COMPANIES,

BY COUNTRY, 2023–2030 (USD MILLION)               216

TABLE 147            EUROPE: INFECTION CONTROL MARKET FOR LIFE SCIENCE INDUSTRY,

BY COUNTRY, 2023–2030 (USD MILLION)               217

TABLE 148            EUROPE: INFECTION CONTROL MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION)                 219

TABLE 149            EUROPE: INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)                 220

TABLE 150            EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            222

TABLE 151            EUROPE: KEY MACROECONOMIC INDICATORS                 225

TABLE 152            EUROPE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            226

TABLE 153            EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 227

TABLE 154            EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            227

TABLE 155            EUROPE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         227

TABLE 156            EUROPE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            228

TABLE 157            EUROPE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            228

TABLE 158            EUROPE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         229

TABLE 159            EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         229

TABLE 160            EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 230

TABLE 161            EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 230

TABLE 162            EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            231

TABLE 163            EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 231

TABLE 164            EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 232

TABLE 165            EUROPE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION)                 232

TABLE 166            EUROPE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION)                 233

TABLE 167            EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 233

TABLE 168            EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                234

TABLE 169            EUROPE: INFECTION CONTROL MARKET, BY END USER,

2023–2030 (USD MILLION)            234

TABLE 170            GERMANY: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            236

TABLE 171            GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 236

TABLE 172            GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         237

TABLE 173            GERMANY: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            237

TABLE 174            GERMANY: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            238

TABLE 175            GERMANY: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            238

TABLE 176            GERMANY: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)            239

TABLE 177            GERMANY: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         239

TABLE 178            GERMANY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 240

TABLE 179            GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 240

TABLE 180            GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            241

TABLE 181            GERMANY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 241

TABLE 182            GERMANY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 242

TABLE 183            GERMANY: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION)                 242

TABLE 184            GERMANY: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION)                 243

TABLE 185            GERMANY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 243

TABLE 186            GERMANY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                244

TABLE 187            GERMANY: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            244

TABLE 188            UK: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            246

TABLE 189            UK: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         246

TABLE 190            UK: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            247

TABLE 191            UK: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         247

TABLE 192            UK: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)       248

TABLE 193            UK: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         248

TABLE 194            UK: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)            249

TABLE 195            UK: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION)            249

TABLE 196            UK: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS,

BY TYPE, 2023–2030 (USD MILLION)         250

TABLE 197            UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 250

TABLE 198            UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            251

TABLE 199            UK: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 251

TABLE 200            UK: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 252

TABLE 201            UK: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE,

2023–2030 (USD MILLION)            252

TABLE 202            UK: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE,

2023–2030 (USD MILLION)            253

TABLE 203            UK: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 253

TABLE 204            UK: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                254

TABLE 205            UK: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION)             254

TABLE 206            FRANCE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            256

TABLE 207            FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 256

TABLE 208            FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            257

TABLE 209            FRANCE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         257

TABLE 210            FRANCE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            258

TABLE 211            FRANCE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            258

TABLE 212            FRANCE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         259

TABLE 213            FRANCE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         259

TABLE 214            FRANCE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 260

TABLE 215            FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 260

TABLE 216            FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            261

TABLE 217            FRANCE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 261

TABLE 218            FRANCE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 262

TABLE 219            FRANCE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION)                 262

TABLE 220            FRANCE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION)                 263

TABLE 221            FRANCE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 263

TABLE 222            FRANCE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                264

TABLE 223            FRANCE: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            264

TABLE 224            ITALY: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            265

TABLE 225            ITALY: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 266

TABLE 226            ITALY: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            266

TABLE 227            ITALY: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         266

TABLE 228            ITALY: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            267

TABLE 229            ITALY: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES,

BY TYPE, 2023–2030 (USD MILLION)         267

TABLE 230            ITALY: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         268

TABLE 231            ITALY: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION)            268

TABLE 232            ITALY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 269

TABLE 233            ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 269

TABLE 234            ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            270

TABLE 235            ITALY: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 270

TABLE 236            ITALY: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 271

TABLE 237            ITALY: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE,

2023–2030 (USD MILLION)            271

TABLE 238            ITALY: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE,

2023–2030 (USD MILLION)            272

TABLE 239            ITALY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 272

TABLE 240            ITALY: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                273

TABLE 241            ITALY: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION)             273

TABLE 242            SPAIN: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            275

TABLE 243            SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 275

TABLE 244            SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         276

TABLE 245            SPAIN: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         276

TABLE 246            SPAIN: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            277

TABLE 247            SPAIN: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            277

TABLE 248            SPAIN: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         278

TABLE 249            SPAIN: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION)            278

TABLE 250            SPAIN: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 279

TABLE 251            SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 279

TABLE 252            SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            280

TABLE 253            SPAIN: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 280

TABLE 254            SPAIN: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 281

TABLE 255            SPAIN: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION)                 281

TABLE 256            SPAIN: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION)                 282

TABLE 257            SPAIN: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 282

TABLE 258            SPAIN: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                283

TABLE 259            SPAIN: INFECTION CONTROL MARKET, BY END USERS, 2023–2030 (USD MILLION)             283

TABLE 260          SWITZERLAND: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            284

TABLE 261            SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION)       285

TABLE 262            SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         285

TABLE 263            SWITZERLAND: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 285

TABLE 264            SWITZERLAND: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                286

TABLE 265            SWITZERLAND: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 286

TABLE 266            SWITZERLAND: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)            287

TABLE 267            SWITZERLAND: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         287

TABLE 268            SWITZERLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)       288

TABLE 269            SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            288

TABLE 270            SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS,

BY FORMULATION TYPE, 2023–2030 (USD MILLION)        289

TABLE 271            SWITZERLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 289

TABLE 272            SWITZERLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)       290

TABLE 273            SWITZERLAND: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS,

BY TYPE, 2023–2030 (USD MILLION)         290

TABLE 274            SWITZERLAND: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS,

BY TYPE, 2023–2030 (USD MILLION)         291

TABLE 275            SWITZERLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)       291

TABLE 276            SWITZERLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)         292

TABLE 277          SWITZERLAND: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            292

TABLE 278            POLAND: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            293

TABLE 279            POLAND: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 294

TABLE 280            POLAND: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            294

TABLE 281            POLAND: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         294

TABLE 282            POLAND: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            295

TABLE 283            POLAND: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            295

TABLE 284            POLAND: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         296

TABLE 285            POLAND: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         296

TABLE 286            POLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 297

TABLE 287            POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 297

TABLE 288            POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            298

TABLE 289            POLAND: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 298

TABLE 290            POLAND: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 299

TABLE 291            POLAND: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS,

BY TYPE, 2023–2030 (USD MILLION)         299

TABLE 292            POLAND: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS,

BY TYPE, 2023–2030 (USD MILLION)         300

TABLE 293            POLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 300

TABLE 294            POLAND: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                301

TABLE 295            POLAND: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            301

TABLE 296            AUSTRIA: REPORTED CASES OF NOTIFIABLE DISEASES             302

TABLE 297            AUSTRIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            303

TABLE 298            AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 303

TABLE 299            AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            304

TABLE 300            AUSTRIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         304

TABLE 301            AUSTRIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            305

TABLE 302            AUSTRIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            305

TABLE 303            AUSTRIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         306

TABLE 304            AUSTRIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         306

TABLE 305            AUSTRIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 307

TABLE 306            AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 307

TABLE 307            AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            308

TABLE 308            AUSTRIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 308

TABLE 309            AUSTRIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 309

TABLE 310            AUSTRIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION)                 309

TABLE 311            AUSTRIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION)                 310

TABLE 312            AUSTRIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 310

TABLE 313            AUSTRIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                311

TABLE 314            AUSTRIA: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            311

TABLE 315            ROMANIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            313

TABLE 316            ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 313

TABLE 317            ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         314

TABLE 318            ROMANIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            314

TABLE 319            ROMANIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            315

TABLE 320            ROMANIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            315

TABLE 321            ROMANIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         316

TABLE 322            ROMANIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         316

TABLE 323            ROMANIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 317

TABLE 324            ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 317

TABLE 325            ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            318

TABLE 326            ROMANIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 318

TABLE 327            ROMANIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 319

TABLE 328            ROMANIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION)                 319

TABLE 329            ROMANIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION)                 320

TABLE 330            ROMANIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 320

TABLE 331            ROMANIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                321

TABLE 332            ROMANIA: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            321

TABLE 333            CZECH REPUBLIC: NUMBER OF INDEPENDENT SURGERIES (2019─2023)                 322

TABLE 334            CZECH REPUBLIC: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            322

TABLE 335            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION)            323

TABLE 336            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 323

TABLE 337            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            323

TABLE 338            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)             324

TABLE 339            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            324

TABLE 340            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)       325

TABLE 341            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 325

TABLE 342            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            326

TABLE 343            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS,

BY PRODUCT TYPE, 2023–2030 (USD MILLION)  326

TABLE 344            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS,

BY FORMULATION TYPE, 2023–2030 (USD MILLION)        327

TABLE 345            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION)            327

TABLE 346            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                328

TABLE 347            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS,

BY TYPE, 2023–2030 (USD MILLION)         328

TABLE 348            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS,

BY TYPE, 2023–2030 (USD MILLION)         329

TABLE 349            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                329

TABLE 350            CZECH REPUBLIC: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)               330

TABLE 351            CZECH REPUBLIC: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            330

TABLE 352            SLOVAKIA: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            331

TABLE 353            SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 331

TABLE 354            SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         332

TABLE 355            SLOVAKIA: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            332

TABLE 356            SLOVAKIA: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            333

TABLE 357            SLOVAKIA: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            333

TABLE 358            SLOVAKIA: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)            334

TABLE 359            SLOVAKIA: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         334

TABLE 360            SLOVAKIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 335

TABLE 361            SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 335

TABLE 362            SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            336

TABLE 363            SLOVAKIA: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 336

TABLE 364            SLOVAKIA: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 337

TABLE 365            SLOVAKIA: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION)                 337

TABLE 366            SLOVAKIA: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION)                 338

TABLE 367            SLOVAKIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION) 338

TABLE 368            SLOVAKIA: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)                339

TABLE 369            SLOVAKIA: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            339

TABLE 370            PORTUGAL: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            340

TABLE 371            PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION)       341

TABLE 372            PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT,

BY TYPE, 2023–2030 (USD MILLION)         341

TABLE 373            PORTUGAL: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 341

TABLE 374            PORTUGAL: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                342

TABLE 375            PORTUGAL: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION) 342

TABLE 376            PORTUGAL: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)            343

TABLE 377            PORTUGAL: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS,

BY TYPE, 2023–2030 (USD MILLION)         343

TABLE 378            PORTUGAL: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)       344

TABLE 379            PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            344

TABLE 380            PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY FORMULATION TYPE, 2023–2030 (USD MILLION)            345

TABLE 381            PORTUGAL: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION) 345

TABLE 382            PORTUGAL: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)       346

TABLE 383            PORTUGAL: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2023–2030 (USD MILLION)            346

TABLE 384            PORTUGAL: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS, BY TYPE, 2023–2030 (USD MILLION)            347

TABLE 385            PORTUGAL: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)       347

TABLE 386            PORTUGAL: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)         348

TABLE 387            PORTUGAL: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            348

TABLE 388            REST OF EUROPE: INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2023–2030 (USD MILLION)            350

TABLE 389            REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION PRODUCTS & SERVICES, BY TYPE, 2023–2030 (USD MILLION)            350

TABLE 390            REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION) 351

TABLE 391            REST OF EUROPE: INFECTION CONTROL MARKET FOR HEAT STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)            351

TABLE 392            REST OF EUROPE: INFECTION CONTROL MARKET FOR LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)             352

TABLE 393            REST OF EUROPE: INFECTION CONTROL MARKET FOR CONTRACT STERILIZATION SERVICES, BY TYPE, 2023–2030 (USD MILLION)            352

TABLE 394            REST OF EUROPE: INFECTION CONTROL MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)       353

TABLE 395            REST OF EUROPE: INFECTION CONTROL MARKET FOR STERILIZATION INDICATORS, BY TYPE, 2023–2030 (USD MILLION) 353

TABLE 396            REST OF EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)            354

TABLE 397            REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS,

BY PRODUCT TYPE, 2023–2030 (USD MILLION)  354

TABLE 398            REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS,

BY FORMULATION TYPE, 2023–2030 (USD MILLION)        355

TABLE 399            REST OF EUROPE: INFECTION CONTROL MARKET FOR DISINFECTANTS, BY EPA CLASSIFICATION TYPE, 2023–2030 (USD MILLION)            355

TABLE 400            REST OF EUROPE: INFECTION CONTROL MARKET FOR CLEANING & DISINFECTANT EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)                356

TABLE 401            REST OF EUROPE: INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS,

BY TYPE, 2023–2030 (USD MILLION)         356

TABLE 402            REST OF EUROPE: INFECTION CONTROL MARKET FOR MEDICAL NONWOVENS,

BY TYPE, 2023–2030 (USD MILLION)         357

TABLE 403            REST OF EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY TYPE, 2023–2030 (USD MILLION)                357

TABLE 404            REST OF EUROPE: INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING EQUIPMENT & SOLUTIONS, BY TYPE, 2023–2030 (USD MILLION)               358

TABLE 405            REST OF EUROPE: INFECTION CONTROL MARKET, BY END USERS,

2023–2030 (USD MILLION)            358

TABLE 406            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN

EUROPEAN INFECTION CONTROL MARKET        359

TABLE 407            EUROPEAN INFECTION CONTROL MARKET: DEGREE OF COMPETITION         362

TABLE 408            EUROPEAN INFECTION CONTROL MARKET: REGION FOOTPRINT     367

TABLE 409            EUROPEAN INFECTION CONTROL MARKET: PRODUCT & SERVICE FOOTPRINT           368

TABLE 410            EUROPEAN INFECTION CONTROL MARKET: END-USER FOOTPRINT 369

TABLE 411            EUROPEAN INFECTION CONTROL MARKET: DETAILED LIST OF

KEY STARTUP/ SME PLAYERS     372

TABLE 412            EUROPEAN INFECTION CONTROL MARKET: COMPETITIVE

BENCHMARKING OF STARTUPS/SMES   373

TABLE 413            EUROPEAN INFECTION CONTROL MARKET: PRODUCT/SERVICE

LAUNCHES, JANUARY 2022–JUNE 2025     376

TABLE 414            EUROPEAN INFECTION CONTROL MARKET: DEALS, JANUARY 2022–JUNE 2025              377

TABLE 415            EUROPEAN INFECTION CONTROL MARKET: EXPANSIONS,

JANUARY 2022–JUNE 2025              378

TABLE 416            STERIS: COMPANY OVERVIEW   379

TABLE 417            STERIS PLC: PRODUCTS/SERVICES OFFERED                 380

TABLE 418            STERIS PLC: DEALS, JANUARY 2022–JUNE 2025                 384

TABLE 419            RECKITT BENCKISER: COMPANY OVERVIEW                 386

TABLE 420            RECKITT BENCKISER: PRODUCTS/SERVICES OFFERED             387

TABLE 421            RECKITT BENCKISER: DEALS, JANUARY 2022– JUNE 2025             388

TABLE 422            PAUL HARTMANN: COMPANY OVERVIEW                 390

TABLE 423            PAUL HARTMANN: PRODUCTS/SERVICES OFFERED             391

TABLE 424            ECOLAB, INC.: COMPANY OVERVIEW     393

TABLE 425            ECOLAB, INC.: PRODUCTS/SERVICES OFFERED                 394

TABLE 426            ECOLAB, INC.: DEALS, JANUARY 2021–JUNE 2025                 401

TABLE 427            ECOLAB, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025              401

TABLE 428            B. BRAUN SE: COMPANY OVERVIEW       403

TABLE 429            B. BRAUN SE: PRODUCTS/SERVICES OFFERED                 404

TABLE 430            B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025              405

TABLE 431            GETINGE AB: COMPANY OVERVIEW       407

TABLE 432            GETINGE AB: PRODUCTS/SERVICES OFFERED                 408

TABLE 433            GETINGE AB: DEALS, JANUARY 2022–JUNE 2025                 413

TABLE 434            GETINGE AB: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025              414

TABLE 435            FORTIVE CORPORATION: COMPANY OVERVIEW          415

TABLE 436            FORTIVE CORPORATION: PRODUCTS/SERVICES OFFERED               416

TABLE 437            SOLVENTUM CORPORATION: COMPANY OVERVIEW          418

TABLE 438            SOLVENTUM CORPORATION: PRODUCTS/SERVICES OFFERED               419

TABLE 439            KIMBERLY CLARK PROFESSIONAL: COMPANY OVERVIEW          424

TABLE 440            KIMBERLY-CLARK CORPORATION: PRODUCTS/SERVICES OFFERED               425

TABLE 441            OLYMPUS CORPORATION: COMPANY OVERVIEW          427

TABLE 442            OLYMPUS CORPORATION: PRODUCTS/SERVICES OFFERED               428

TABLE 443            OLYMPUS CORPORATION: DEALS, JANUARY 2022–JUNE 2025  429

TABLE 444            OLYMPUS CORPORATION: PRODUCT/SERVICE LAUNCHES,

JANUARY 2022–JUNE 2025              430

TABLE 445            OLYMPUS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025         431

TABLE 446            CARDINAL HEALTH: COMPANY OVERVIEW                 432

TABLE 447            CARDINAL HEALTH: PRODUCTS/SERVICES OFFERED             433

TABLE 448            CARDINAL HEALTH: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025              435

TABLE 449            THE MIELE GROUP: COMPANY OVERVIEW                 436

TABLE 450            THE MIELE GROUP: PRODUCTS/SERVICES OFFERED             436

TABLE 451            THE MIELE GROUP: DEALS, JANUARY 2022–JUNE 2025        443

TABLE 452            MMM GROUP: COMPANY OVERVIEW     444

TABLE 453            MMM GROUP: PRODUCTS/SERVICES OFFERED                 444

TABLE 454            MMM GROUP: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–JUNE 2025              446

TABLE 455            MATACHANA GROUP: COMPANY OVERVIEW                 447

TABLE 456            MATACHANA GROUP: PRODUCTS/SERVICES OFFERED             447

TABLE 457            MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW          450

TABLE 458            MEDLINE INDUSTRIES, LP: PRODUCTS/SERVICES OFFERED               450

TABLE 459            CONTEC, INC.: COMPANY OVERVIEW    452

TABLE 460            DE LAMA SPA: COMPANY OVERVIEW     455

TABLE 461            SYSTEC GMBH & CO. KG: COMPANY OVERVIEW                 456

TABLE 462            PAL INTERNATIONAL: COMPANY OVERVIEW                 457

TABLE 463            MELAG MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW   459

TABLE 464            MEDALKAN: COMPANY OVERVIEW         460

TABLE 465            C.B.M. S.R.L. MEDICAL EQUIPMENT: COMPANY OVERVIEW          462

TABLE 466            DR. SCHUMACHER GMBH: COMPANY OVERVIEW          463

TABLE 467            ACTO GMBH: COMPANY OVERVIEW       464

TABLE 468            ULTRAWAVE: COMPANY OVERVIEW      465

LIST OF FIGURES

FIGURE 1              MARKET SEGMENTATION           37

FIGURE 2              EUROPEAN INFECTION CONTROL MARKET: RESEARCH DESIGN         40

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE AND DESIGNATION     44

FIGURE 4              BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH              45

FIGURE 5              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 46

FIGURE 6              EUROPEAN INFECTION CONTROL MARKET: TOP-DOWN APPROACH                47

FIGURE 7              DATA TRIANGULATION METHODOLOGY                 48

FIGURE 8              EUROPEAN INFECTION CONTROL MARKET: IMPACT ASSESSMENT ANALYSIS               49

FIGURE 9              EUROPEAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE,

2025 VS. 2030 (USD MILLION)      51

FIGURE 10            EUROPEAN INFECTION CONTROL MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      52

FIGURE 11            EUROPEAN INFECTION CONTROL MARKET, BY COUNTRY,

2025 VS. 2030 (USD MILLION)      53

FIGURE 12            RISING INCIDENCE OF HAIS AND STRINGENT IMPLEMENTATION OF INFECTION CONTROL PROTOCOL MEASURES TO PROPEL MARKET               55

FIGURE 13            CLEANING & DISINFECTION PRODUCTS & SERVICES ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2024            56

FIGURE 14            GERMANY TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030              57

FIGURE 15            GERMANY TO DOMINATE MARKET DURING FORECAST PERIOD         58

FIGURE 16            EUROPEAN INFECTION CONTROL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 59

FIGURE 17            EUROPEAN INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS               74

FIGURE 18            EUROPEAN INFECTION CONTROL MARKET: SUPPLY CHAIN ANALYSIS             75

FIGURE 19            EUROPEAN INFECTION CONTROL MARKET: ECOSYSTEM MAPPING  76

FIGURE 20            EUROPEAN INFECTION CONTROL MARKET: PORTER’S FIVE FORCES ANALYSIS           80

FIGURE 21            EUROPEAN INFECTION CONTROL MARKET: PATENT ANALYSIS, 2014–2024     86

FIGURE 22            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           90

FIGURE 23            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE PRODUCTS  91

FIGURE 24            KEY BUYING CRITERIA FOR TOP THREE PRODUCTS         92

FIGURE 25            EUROPEAN INFECTION CONTROL MARKET: INVESTMENT &

FUNDING ACTIVITIES, 2022−2025             93

FIGURE 26            AI USE CASES     95

FIGURE 27            EUROPE: EUROPEAN INFECTION CONTROL MARKET SNAPSHOT       224

FIGURE 28            ROMANIA: POPULATION AGED 65 & ABOVE (2020−2024)        312

FIGURE 29            REVENUE ANALYSIS OF KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET, 2020–2024  361

FIGURE 30            MARKET SHARE ANALYSIS OF KEY PLAYERS IN EUROPEAN INFECTION CONTROL MARKET (2024)           362

FIGURE 31            EUROPEAN INFECTION CONTROL MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       365

FIGURE 32            EUROPEAN INFECTION CONTROL MARKET: COMPANY FOOTPRINT 366

FIGURE 33            EUROPEAN INFECTION CONTROL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 371

FIGURE 34            EV/EBITDA OF KEY VENDORS, 2025         374

FIGURE 35            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS, 2025 374

FIGURE 36            EUROPEAN INFECTION CONTROL MARKET: BRAND/PRODUCT COMPARISON             375

FIGURE 37            STERIS PLC: COMPANY SNAPSHOT (2024)                 380

FIGURE 38            RECKITT BENCKISER: COMPANY SNAPSHOT (2024)    387

FIGURE 39            PAUL HARTMANN: COMPANY SNAPSHOT (2024)                 391

FIGURE 40            ECOLAB, INC.: COMPANY SNAPSHOT (2024)                 394

FIGURE 41            B. BRAUN SE: COMPANY SNAPSHOT (2024)                 404

FIGURE 42            GETINGE AB: COMPANY SNAPSHOT (2024)                 408

FIGURE 43            FORTIVE CORPORATION: COMPANY SNAPSHOT (2024)             416

FIGURE 44            SOLVENTUM CORPORATION: COMPANY SNAPSHOT (2024)             419

FIGURE 45            KIMBERLY CLARK CORPORATION: COMPANY SNAPSHOT (2024)             425

FIGURE 46            OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)             428

FIGURE 47            CARDINAL HEALTH: COMPANY SNAPSHOT (2024)    433